Síndrome da lipodistrofia e fatores de risco cardiovasculares em crianças e adolescentes infectados pelo HIV/AIDS em uso de terapia antirretroviral de alta potência

Werner, Maria L. F; Pone, Marcos V. da S; Fonseca, Vânia M; Chaves, Célia R. M. de M.
J. pediatr. (Rio J.) ; 86(1): 27-32, jan.-fev. 2010. tab
Artículo en Inglés, Portugués | LILACS | ID: lil-542899

Documentos relacionados

  1. Sex-specific fat mass ratio cutoff value identifies a high prevalence of cardio-metabolic disorders in people living with HIV.
  2. Association between lipodystrophy and length of exposure to ARTs in adult HIV-1 infected patients in Montreal.
  3. [10 years of lipodystrophy--and so many uncertainties].
  4. [A study of HIV-related lipodystrophy syndrome in 55 HIV-infected Chinese adult patients].
  5. COHORT PROFILE: The Complications of Long-Term Antiretroviral Therapy study in Uganda (CoLTART), a prospective clinical cohort.
  6. High prevalence of lipoatrophy in pre-pubertal South African children on antiretroviral therapy: a cross-sectional study.
  7. Identification of novel genetic variations in ABCB6 and GRN genes associated with HIV-associated lipodystrophy.
  8. Human immunodeficiency virus & cardiovascular risk.
  9. Association between changes in body fat distribution, biochemical profile, time of HIV diagnosis, and antiretroviral treatment in adults living with and without virus infection.
  10. Kager's fat pad inflammation associated with HIV infection and AIDS: MRI findings.